Sandu Pharmaceuticals Ltd — Important, 19-11-2025: Company Update

Sandu Pharmaceuticals shareholders have approved the reclassification of Akshath Finvest and Properties Private Limited from the 'Promoter/Promoter Group' to the 'Public' category through a postal ballot. This approval significantly alters the company's ownership structure. Post-reclassification, the promoter shareholding now stands at 37.79%, down from 42.90%, while the public shareholding has increased to 62.21% from 57.10%. This shift effectively boosts the public float, which could potentially enhance the stock's liquidity and accessibility for retail investors.